AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030

1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.2.1 TELEHEALTH 35 1.2.2 TELEMEDICINE 35 1.3 STUDY SCOPE 36 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 36 1.3.2 INCLUSIONS & EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.3.4 CURRENCY CONSIDERED 39 1.4 STAKEHOLDERS 39 2 RESEARCH METHODOLOGY 41 2.1 RESEARCH DATA 41 2.1.1 SECONDARY DATA 42 2.1.1.1 Key sources for secondary data 42 2.1.1.2 Key data from secondary sources 43 2.1.2 PRIMARY DATA 43 2.1.2.1 Key sources for primary data 44 2.1.2.2 Key objectives of primary research 44 2.1.2.3 Key data from primary sources 45 2.1.2.4 Insights from primary experts 46 2.2 MARKET SIZE ESTIMATION 47 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 47 2.2.2 TOP-DOWN APPROACH 48 2.3 DATA TRIANGULATION 52 2.4 MARKET SHARE ESTIMATION 53 2.5 STUDY ASSUMPTIONS 53 2.6 RESEARCH LIMITATIONS 53 2.6.1 METHODOLOGY-RELATED LIMITATIONS 53 2.6.2 SCOPE-RELATED LIMITATIONS 54 2.7 RISK ANALYSIS 54 3 EXECUTIVE SUMMARY 55   4 PREMIUM INSIGHTS 60 4.1 AI IN TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 60 4.2 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY 61 4.3 AI IN TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 62 4.4 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS 63 5 MARKET OVERVIEW 64 5.1 INTRODUCTION 64 5.2 MARKET DYNAMICS 64 5.2.1 DRIVERS 65 5.2.1.1 Increasing adoption of virtual assistant chatbots 65 5.2.1.2 Rising popularity of e-prescriptions 66 5.2.1.3 Growing adoption of EHRs in healthcare settings 66 5.2.1.4 Advancements in digital health technologies 67 5.2.1.5 Shortage of skilled healthcare professionals 68 5.2.2 RESTRAINTS 68 5.2.2.1 Regulatory variations across regions 68 5.2.2.2 Lack of advanced telemedicine infrastructure in emerging economies 69 5.2.3 OPPORTUNITIES 69 5.2.3.1 Growing popularity of virtual healthcare solutions 69 5.2.3.2 Emergence of AI and ML 69 5.2.3.3 Favorable government initiatives and reimbursement policies 70 5.2.3.4 Rising focus on home healthcare 70 5.2.3.5 Expansion of remote patient monitoring markets 71 5.2.4 CHALLENGES 72 5.2.4.1 Increasing data breaches and medical identity theft cases 72 5.2.4.2 Complexities of big data in healthcare 75 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 75 5.4 INDUSTRY TRENDS 76 5.4.1 GEN AI FOR MEDICAL DOCUMENTATION 76 5.4.2 INNOVATIONS IN REMOTE PATIENT MONITORING DEVICES 76 5.5 ECOSYSTEM ANALYSIS 76 5.5.1 ROLE IN ECOSYSTEM 78 5.6 VALUE CHAIN ANALYSIS 79 5.7 TECHNOLOGY ANALYSIS 80 5.7.1 KEY TECHNOLOGIES 80 5.7.1.1 Video conferencing and real-time communication platforms 80 5.7.1.2 Virtual assistants and chatbots 80 5.7.1.3 Voice recognition and natural language processing 80 5.7.1.4 EHR integration 81 5.7.1.5 Remote patient monitoring systems 81 5.7.2 COMPLEMENTARY TECHNOLOGIES 81 5.7.2.1 Cloud computing 81 5.7.2.2 mHealth applications 81 5.7.2.3 Wearable devices, sensors, and IoT 82 5.7.3 ADJACENT TECHNOLOGIES 82 5.7.3.1 Digital therapeutics 82 5.7.3.2 Blockchain technologies 82 5.7.3.3 Augmented reality and virtual reality 82 5.8 TARIFF & REGULATORY ANALYSIS 83 5.8.1 TARIFF DATA ANALYSIS 83 5.8.1.1 Average tariff for HS code 9018 83 5.8.1.2 Average tariff for HS code 9021 84 5.8.1.3 Average tariff for HS code 9022 85 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 5.8.3 REGULATORY STANDARDS 89 5.8.4 REGULATORY REQUIREMENTS 90 5.9 TRADE ANALYSIS 92 5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099, 2019–2023 93 5.9.1.1 Top 10 importers for HSN code 90189099 93 5.9.1.2 Top 10 exporters for HSN code 90189099 93 5.9.2 TRADE ANALYSIS FOR HSN CODE 9021, 2019–2023 94 5.9.2.1 Top 10 importers for HSN code 9021 94 5.9.2.2 Top 10 exporters for HSN code 9021 94 5.9.3 TRADE ANALYSIS FOR HSN CODE 9022, 2019–2023 95 5.9.3.1 Top 10 importers for HSN code 9022 95 5.9.3.2 Top 10 exporters for HSN code 9022 95 5.10 PRICING ANALYSIS 96 5.10.1 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023 97 5.10.2 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024 98 5.10.3 PRICING MODELS 99 5.11 PORTER’S FIVE FORCES ANALYSIS 99 5.11.1 INTENSITY OF COMPETITIVE RIVALRY 101 5.11.2 THREAT OF NEW ENTRANTS 101 5.11.3 THREAT OF SUBSTITUTES 101 5.11.4 BARGAINING POWER OF BUYERS 101 5.11.5 BARGAINING POWER OF SUPPLIERS 102 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 102 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 102 5.12.2 KEY BUYING CRITERIA 103   5.13 PATENT ANALYSIS 104 5.13.1 PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 104 5.13.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 105 5.14 UNMET NEEDS & END-USER EXPECTATIONS 106 5.14.1 UNMET NEEDS 106 5.14.2 END-USER EXPECTATIONS 107 5.15 KEY CONFERENCES & EVENTS, 2025–2026 108 5.16 CASE STUDY ANALYSIS 110 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION 110 5.16.2 TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS 110 5.16.3 LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING 111 5.17 INVESTMENT & FUNDING SCENARIO 111 5.18 BUSINESS MODEL ANALYSIS 112 5.18.1 DIRECT-TO-PATIENT (D2P) MODELS 112 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODELS 112 5.18.3 EMPLOYER-SPONSORED MODELS 112 5.18.4 SUBSCRIPTION-BASED MODELS 112 5.18.5 HYBRID TELEMEDICINE MODELS 112 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODELS 113 5.18.7 VALUE-BASED CARE MODELS 113 5.19 REIMBURSEMENT SCENARIO ANALYSIS 113 6 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 116 6.1 INTRODUCTION 117 6.2 HARDWARE 117 6.2.1 HIGH DEMAND FOR REMOTE PATIENT MONITORING DEVICES TO SPUR MARKET GROWTH 117 6.3 SOFTWARE 119 6.3.1 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY 120 6.3.1.1 EHR-centric software 120 6.3.1.1.1 EHR-centric software to facilitate better care coordination and streamline administrative tasks 120 6.3.1.2 Non-EHR-centric software 121 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate remote telehealth services 121 6.3.2 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE 122 6.3.2.1 Integrated software 123 6.3.2.1.1 Better accessibility and efficiency in integrated software to revolutionize patient care 123 6.3.2.2 Standalone software 124 6.3.2.2.1 Flexibility and ease of usage to fuel uptake for high-quality remote patient care 124 6.3.3 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT 125 6.3.3.1 On-premises deployment 126 6.3.3.1.1 On-premises deployment to enhance safety and control of inventory data 126 6.3.3.2 Cloud-based deployment 127 6.3.3.2.1 Cost-effectiveness and easy optimization of complex IT systems to boost market growth 127 6.4 SERVICES 128 6.4.1 TELEHEALTH SERVICES TO REDUCE IN-PERSON CLINIC VISITS AND ENSURE BETTER TREATMENT ACCESSIBILITY FOR REMOTE AREAS 128 7 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 130 7.1 INTRODUCTION 131 7.2 VIRTUAL CARE CONSULTATION 131 7.2.1 AI-BASED VIRTUAL CARE PLANS TO AUTOMATE DOCUMENTATION AND OFFER BETTER CLINICAL DECISION SUPPORT 131 7.3 CHATBOTS & VIRTUAL ASSISTANTS 132 7.3.1 CHATBOTS & VIRTUAL ASSISTANTS TO ENHANCE PATIENT ENGAGEMENT AND PROVIDE REAL-TIME HEALTH SUPPORT 132 7.4 REMOTE PATIENT MONITORING 133 7.4.1 EFFECTIVE REAL-TIME DISEASE MONITORING WITHOUT IN-PATIENT VISITS TO DRIVE MARKET 133 7.5 VIRTUAL NURSING CARE PLATFORMS 134 7.5.1 VIRTUAL NURSING PLATFORMS TO ELIMINATE NURSING SHORTAGES, REDUCE BURNOUT, AND PROVIDE HIGH-QUALITY CARE 134 7.6 CLINICAL DOCUMENTATION 135 7.6.1 NEED FOR ACCURATE AND COMPLIANT MEDICAL RECORDS FOR VIRTUAL CONSULTATIONS TO AUGMENT MARKET GROWTH 135 7.7 ADMINISTRATIVE WORKFLOW 136 7.7.1 EFFECTIVE RESOURCE MANAGEMENT AND OPERATIONAL EFFICIENCY TO AID MARKET GROWTH 136 7.8 ANALYTICS & REPORTING 137 7.8.1 ADVANCED ANALYTICS & REPORTING TOOLS TO FOSTER BETTER CARE COORDINATION AND PROVIDE PERSONALIZED TREATMENTS 137 7.9 PATIENT ENGAGEMENT 138 7.9.1 BETTER PATIENT ENGAGEMENT TO ADVANCE HEALTHCARE DELIVERY AND PROMOTE BETTER ADHERENCE TO TREATMENT PLANS 138 7.10 OTHER FUNCTIONS 139 8 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 141 8.1 INTRODUCTION 142 8.2 PRIMARY CARE APPLICATIONS 142 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND DEMAND FOR PERSONALIZED HEALTHCARE DELIVERY TO PROPEL MARKET GROWTH 142 8.3 SPECIALTY CARE APPLICATIONS 143 8.3.1 TELERADIOLOGY 145 8.3.1.1 Reduced turnaround time for imaging reports and better access to radiologists in remote areas to support market growth 145 8.3.2 TELECARDIOLOGY 146 8.3.2.1 Real-time ECG interpretations and remote cardiac care for chronic patients to augment market growth 146 8.3.3 TELENEUROLOGY 146 8.3.3.1 Growing focus on advanced neurological care without in-person visits to aid market growth 146 8.3.4 DIABETES 147 8.3.4.1 Rising prevalence of diabetes to drive market 147 8.3.5 RESPIRATORY DISORDERS 148 8.3.5.1 Increasing incidence of respiratory diseases among geriatric population to propel market growth 148 8.3.6 HYPERTENSION 149 8.3.6.1 Need for constant monitoring and high prevalence of hypertension to boost market growth 149 8.3.7 TELEDERMATOLOGY 150 8.3.7.1 Increased occurrence of skin cancer to fuel market growth 150 8.3.8 TELEPSYCHIATRY 150 8.3.8.1 Shortage of mental health practitioners in rural areas to fuel uptake 150 8.3.9 OTHER SPECIALTY CARE APPLICATIONS 151 8.4 TELEICU 152 8.4.1 INCREASE IN EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF ER SPECIALISTS TO PROPEL MARKET GROWTH 152 8.5 OTHER APPLICATIONS 152 9 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER 154 9.1 INTRODUCTION 155 9.2 HEALTHCARE PROVIDERS 155 9.2.1 HOSPITALS 157 9.2.1.1 Growing incidence of chronic diseases and increasing demand for high-quality care to aid market growth 157 9.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 158 9.2.2.1 Cost-effectiveness and reduced patient downtime to augment market growth 158 9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 159 9.2.3.1 Need for prolonged treatment for chronic diseases to support market growth 159 9.2.4 HOME HEALTHCARE 160 9.2.4.1 Demand for cost-effective solutions and low hospital readmissions to propel segment growth 160 9.2.5 OTHER HEALTHCARE PROVIDERS 160 9.3 HEALTHCARE PAYERS 161 9.3.1 HEALTHCARE PAYERS TO REDUCE OVERHEAD COSTS, MINIMIZE PAPER TRAILS, AND IMPROVE MEMBER SERVICES 161 9.4 PATIENTS 162 9.4.1 EMERGENCE OF ADVANCED WEARABLE DEVICES AND USE OF AI IN PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH 162 9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 163 9.5.1 NEED FOR STREAMLINED DRUG DEVELOPMENT PROCESSES AND ENHANCED CLINICAL TRIAL PARTICIPATION TO DRIVE MARKET 163 9.6 MEDTECH COMPANIES 164 9.6.1 MEDTECH COMPANIES TO IMPROVE DIAGNOSTIC ACCURACY AND FACILITATE PERSONALIZED TREATMENT PLANS 164 9.7 OTHER END USERS 165 10 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION 167 10.1 INTRODUCTION 168 10.2 NORTH AMERICA 168 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 168 10.2.2 US 174 10.2.2.1 US to dominate North American market during forecast period 174 10.2.3 CANADA 179 10.2.3.1 Government initiatives on digital health integration to drive adoption of telehealth and mHealth applications 179 10.3 EUROPE 183 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 183 10.3.2 GERMANY 188 10.3.2.1 Favorable government initiatives to support market growth 188 10.3.3 UK 193 10.3.3.1 Growing reliance on digital healthcare platforms and increasing investments in remote mental health services to drive market 193 10.3.4 FRANCE 197 10.3.4.1 Favorable reimbursement for telemedicine solutions to spur market growth 197 10.3.5 ITALY 202 10.3.5.1 Strategic government regulations and high investments in healthcare digitalization to augment market growth 202 10.3.6 SPAIN 206 10.3.6.1 Rapid expansion of eHealth sector and increased adoption of wearable technologies to favor market growth 206 10.3.7 REST OF EUROPE 211 10.4 ASIA PACIFIC 215 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 221 10.4.2 CHINA 221 10.4.2.1 Increasing private sector investments in digital infrastructure to boost market growth 221 10.4.3 JAPAN 226 10.4.3.1 High geriatric population and strong technological infrastructure to propel market growth 226 10.4.4 INDIA 230 10.4.4.1 Increased government focus on digital transformation in rural areas to aid market growth 230 10.4.5 REST OF ASIA PACIFIC 235 10.5 LATIN AMERICA 239 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240 10.5.2 BRAZIL 244 10.5.2.1 Increasing adoption of digital health solutions in public and private systems to aid market growth 244 10.5.3 MEXICO 249 10.5.3.1 Favorable regulatory scenario to fuel market growth 249 10.5.4 REST OF LATIN AMERICA 254 10.6 MIDDLE EAST & AFRICA 258 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 258 10.6.2 GCC COUNTRIES 263 10.6.2.1 Shortage of skilled healthcare workforce to support market growth 263 10.6.3 REST OF MIDDLE EAST & AFRICA 268 11 COMPETITIVE LANDSCAPE 273 11.1 INTRODUCTION 273 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 273 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET 273 11.3 REVENUE ANALYSIS, 2020–2024 276 11.4 MARKET SHARE ANALYSIS, 2023 277 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 279 11.5.1 STARS 279 11.5.2 EMERGING LEADERS 279 11.5.3 PERVASIVE PLAYERS 280 11.5.4 PARTICIPANTS 280 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 281 11.5.5.1 Company footprint 281 11.5.5.2 Region footprint 282 11.5.5.3 Function footprint 283 11.5.5.4 Application footprint 284 11.5.5.5 Component footprint 285 11.5.5.6 End-user footprint 286   11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 287 11.6.1 PROGRESSIVE COMPANIES 287 11.6.2 RESPONSIVE COMPANIES 287 11.6.3 DYNAMIC COMPANIES 287 11.6.4 STARTING BLOCKS 287 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 289 11.6.5.1 Detailed list of key startups/SMEs 289 11.6.5.2 Competitive benchmarking of key startups/SMEs, by region 289 11.7 COMPANY VALUATION & FINANCIAL METRICS 290 11.7.1 FINANCIAL METRICS 290 11.7.2 COMPANY VALUATION 290 11.8 BRAND/SOFTWARE COMPARISON 291 11.9 COMPETITIVE SCENARIO 292 11.9.1 PRODUCT LAUNCHES & APPROVALS 292 11.9.2 DEALS 293 12 COMPANY PROFILE 294 12.1 KEY PLAYERS 294 12.1.1 MEDTRONIC 294 12.1.1.1 Business overview 294 12.1.1.2 Products/Services/Solutions offered 296 12.1.1.3 Recent developments 297 12.1.1.3.1 Product launches and approvals 297 12.1.1.3.2 Deals 298 12.1.1.4 MnM view 299 12.1.1.4.1 Right to win 299 12.1.1.4.2 Strategic choices 299 12.1.1.4.3 Weaknesses & competitive threats 299 12.1.2 TELADOC HEALTH, INC. 300 12.1.2.1 Business overview 300 12.1.2.2 Products/Services/Solutions offered 302 12.1.2.3 Recent developments 303 12.1.2.3.1 Product launches and upgrades 303 12.1.2.3.2 Deals 304 12.1.2.4 MnM view 305 12.1.2.4.1 Right to win 305 12.1.2.4.2 Strategic choices 305 12.1.2.4.3 Weaknesses & competitive threats 305 12.1.3 KONINKLIJKE PHILIPS N.V. 306 12.1.3.1 Business overview 306 12.1.3.2 Products/Services/Solutions offered 307 12.1.3.3 Recent developments 309 12.1.3.3.1 Product approvals 309 12.1.3.3.2 Deals 309 12.1.3.4 MnM view 310 12.1.3.4.1 Right to win 310 12.1.3.4.2 Strategic choices 310 12.1.3.4.3 Weaknesses & competitive threats 310 12.1.4 CISCO SYSTEMS, INC. 311 12.1.4.1 Business overview 311 12.1.4.2 Products/Services/Solutions offered 313 12.1.4.3 Recent developments 314 12.1.4.3.1 Product launches 314 12.1.4.3.2 Deals 314 12.1.4.4 MnM view 314 12.1.4.4.1 Right to win 314 12.1.4.4.2 Strategic choices 315 12.1.4.4.3 Weaknesses & competitive threats 315 12.1.5 GE HEALTHCARE 316 12.1.5.1 Business overview 316 12.1.5.2 Products/Services/Solutions offered 318 12.1.5.3 Recent developments 319 12.1.5.3.1 Product launches and approvals 319 12.1.5.3.2 Deals 319 12.1.5.4 MnM view 320 12.1.5.4.1 Right to win 320 12.1.5.4.2 Strategic choices 320 12.1.5.4.3 Weaknesses & competitive threats 320 12.1.6 EPIC SYSTEMS CORPORATION 321 12.1.6.1 Business overview 321 12.1.6.2 Products/Services/Solutions offered 322 12.1.6.3 Recent developments 323 12.1.6.3.1 Product launches and upgrades 323 12.1.6.3.2 Deals 324 12.1.7 ORACLE 325 12.1.7.1 Business overview 325 12.1.7.2 Products/Services/Solutions offered 327 12.1.7.3 Recent developments 328 12.1.7.3.1 Product launches 328 12.1.7.3.2 Deals 329 12.1.8 DOXIMITY, INC. 331 12.1.8.1 Business overview 331 12.1.8.2 Products/Services/Solutions offered 332 12.1.8.3 Recent developments 333 12.1.8.3.1 Product upgrades 333 12.1.8.3.2 Deals 333 12.1.8.3.3 Other developments 334 12.1.9 INCLUDED HEALTH, INC. 335 12.1.9.1 Business overview 335 12.1.9.2 Products/Services/Solutions offered 335 12.1.9.3 Recent developments 336 12.1.9.3.1 Deals 336 12.1.9.3.2 Other developments 337 12.1.10 ZOOM COMMUNICATIONS, INC. 338 12.1.10.1 Business overview 338 12.1.10.2 Products/Services/Solutions offered 339 12.1.10.3 Recent developments 340 12.1.10.3.1 Deals 340 12.1.11 AMERICAN WELL 341 12.1.11.1 Business overview 341 12.1.11.2 Products/Services/Solutions offered 342 12.1.11.3 Recent developments 343 12.1.11.3.1 Product launches 343 12.1.11.3.2 Deals 344 12.1.11.3.3 Other developments 344 12.1.12 SIEMENS HEALTHINEERS AG 345 12.1.12.1 Business overview 345 12.1.12.2 Products/Services/Solutions offered 346 12.1.12.3 Recent developments 347 12.1.12.3.1 Product approvals 347 12.1.13 AMC HEALTH 348 12.1.13.1 Business overview 348 12.1.13.2 Products/Services/Solutions offered 348 12.1.13.3 Recent developments 349 12.1.13.3.1 Deals 349 12.1.14 TELESPECIALISTS 350 12.1.14.1 Business overview 350 12.1.14.2 Products/Services/Solutions offered 350 12.1.14.3 Recent developments 351 12.1.14.3.1 Product launches 351 12.1.14.3.2 Deals 351 12.1.14.3.3 Other developments 352 12.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 353 12.1.15.1 Business overview 353 12.1.15.2 Products/Services/Solutions offered 354 12.1.15.3 Recent developments 355 12.1.15.3.1 Product launches 355 12.1.15.3.2 Expansions 355 12.1.16 CAREGILITY 356 12.1.16.1 Business overview 356 12.1.16.2 Products/Services/Solutions offered 356 12.1.16.3 Recent developments 357 12.1.16.3.1 Product launches and upgrades 357 12.1.16.3.2 Deals 357 12.1.16.3.3 Other developments 358 12.1.17 CVS HEALTH 359 12.1.17.1 Business overview 359 12.1.17.2 Products/Services/Solutions offered 360 12.1.17.3 Recent developments 361 12.1.17.3.1 Product launches and upgrades 361 12.1.18 ALIVECOR, INC. 362 12.1.18.1 Business overview 362 12.1.18.2 Products/Services/Solutions offered 362 12.1.18.3 Recent developments 363 12.1.18.3.1 Product launches and approvals 363 12.1.18.3.2 Deals 364 12.1.18.3.3 Other developments 365 12.1.19 ELATION 366 12.1.19.1 Business overview 366 12.1.19.2 Products/Services/Solutions offered 366 12.1.19.3 Recent developments 367 12.1.19.3.1 Deals 367 12.1.20 HEALTHTAP, INC. 368 12.1.20.1 Business overview 368 12.1.20.2 Products/Services/Solutions offered 368 12.1.20.3 Recent developments 369 12.1.20.3.1 Product launches 369 12.1.20.3.2 Deals 369 12.2 OTHER PLAYERS 370 12.2.1 CURAI HEALTH 370 12.2.2 ANDOR HEALTH 371 12.2.3 K HEALTH 372 12.2.4 TRANSCARENT 373 12.2.5 BIOINTELLISENSE, INC. 374   13 APPENDIX 375 13.1 DISCUSSION GUIDE 375 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 381 13.3 CUSTOMIZATION OPTIONS 383 13.4 RELATED REPORTS 383 13.5 AUTHOR DETAILS 384

TABLE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS 37 TABLE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS 53 TABLE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RISK ANALYSIS 54 TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 TABLE 5 RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS 72 TABLE 6 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024 74 TABLE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 78 TABLE 8 AVERAGE TARIFF FOR HS CODE 9018 IN 2023 83 TABLE 9 AVERAGE TARIFF FOR HS CODE 9021 IN 2023 84 TABLE 10 AVERAGE TARIFF FOR HS CODE 9022 IN 2023 85 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS 89 TABLE 15 REGULATORY REQUIREMENTS IN NORTH AMERICA 90 TABLE 16 REGULATORY REQUIREMENTS IN EUROPE 91 TABLE 17 REGULATORY REQUIREMENTS IN ASIA PACIFIC 91 TABLE 18 REGULATORY REQUIREMENTS IN LATIN AMERICA 92 TABLE 19 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 92 TABLE 20 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 93 TABLE 21 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 93 TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 94 TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 94 TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 95 TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 95 TABLE 26 COST RANGE INVOLVED IN AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (USD) 96 TABLE 27 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023 97 TABLE 28 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS 97 TABLE 29 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024 (USD) 98 TABLE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 101 TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 103 TABLE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 103 TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 105 TABLE 34 AI IN TELEHEALTH & TELEMEDICINE MARKET: UNMET NEEDS 107 TABLE 35 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER EXPECTATIONS 107 TABLE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 108 TABLE 37 CASE STUDY 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION 110 TABLE 38 CASE STUDY 2: TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS 110 TABLE 39 CASE STUDY 3: LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING 111 TABLE 40 AI IN TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS 114 TABLE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 117 TABLE 42 MAJOR COMPANIES OFFERING HARDWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 118 TABLE 43 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 44 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022–2030 (THOUSAND UNITS) 118 TABLE 45 MAJOR COMPANIES OFFERING SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 119 TABLE 46 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 119 TABLE 47 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 120 TABLE 48 MAJOR COMPANIES OFFERING EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 121 TABLE 49 EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 121 TABLE 50 MAJOR COMPANIES OFFERING NON-EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 122 TABLE 51 NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 122 TABLE 52 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 123 TABLE 53 MAJOR COMPANIES OFFERING INTEGRATED SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 123 TABLE 54 INTEGRATED SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 124 TABLE 55 MAJOR COMPANIES OFFERING STANDALONE SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 124 TABLE 56 STANDALONE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 125 TABLE 57 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 125 TABLE 58 ON-PREMISES DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION) 126 TABLE 59 MAJOR COMPANIES OFFERING CLOUD-BASED DEPLOYMENT FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 127 TABLE 60 CLOUD-BASED DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 61 MAJOR COMPANIES OFFERING AI-BASED TELEHEALTH & TELEMEDICINE SERVICES 128 TABLE 62 AI IN TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 129 TABLE 63 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 131 TABLE 64 MAJOR COMPANIES OFFERING VIRTUAL CARE CONSULTATIONS 132 TABLE 65 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE CONSULTATION, BY REGION, 2022–2030 (USD MILLION) 132 TABLE 66 MAJOR COMPANIES OFFERING CHATBOTS & VIRTUAL ASSISTANTS 133 TABLE 67 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CHATBOTS & VIRTUAL ASSISTANTS, BY REGION, 2022–2030 (USD MILLION) 133 TABLE 68 MAJOR COMPANIES OFFERING REMOTE PATIENT MONITORING 134 TABLE 69 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION) 134 TABLE 70 MAJOR COMPANIES OFFERING VIRTUAL NURSING CARE 135 TABLE 71 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL NURSING CARE PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 135 TABLE 72 MAJOR COMPANIES OFFERING CLINICAL DOCUMENTATION 136 TABLE 73 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL DOCUMENTATION, BY REGION, 2022–2030 (USD MILLION) 136 TABLE 74 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE WORKFLOW, BY REGION, 2022–2030 (USD MILLION) 137 TABLE 75 MAJOR COMPANIES OFFERING ANALYTICS & REPORTING 137 TABLE 76 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022–2030 (USD MILLION) 138 TABLE 77 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022–2030 (USD MILLION) 139 TABLE 78 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 140 TABLE 79 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 142 TABLE 80 MAJOR COMPANIES OFFERING PRIMARY CARE APPLICATIONS 143 TABLE 81 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 143 TABLE 82 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 144 TABLE 83 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 144 TABLE 84 TELERADIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 145 TABLE 85 TELECARDIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 146 TABLE 86 TELENEUROLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 147 TABLE 87 MAJOR COMPANIES OFFERING SOLUTIONS FOR DIABETES 147 TABLE 88 DIABETES MARKET, BY REGION 2022–2030 (USD MILLION) 148 TABLE 89 MAJOR COMPANIES OFFERING SOLUTIONS FOR RESPIRATORY DISORDERS 148 TABLE 90 RESPIRATORY DISORDERS MARKET, BY REGION, 2022–2030 (USD MILLION) 149 TABLE 91 HYPERTENSION MARKET, BY REGION, 2022–2030 (USD MILLION) 149 TABLE 92 TELEDERMATOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 150 TABLE 93 TELEPSYCHIATRY MARKET, BY REGION, 2022–2030 (USD MILLION) 151 TABLE 94 OTHER SPECIALTY CARE APPLICATIONS MARKET, BY REGION, 2022–2030 (USD MILLION) 151 TABLE 95 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022–2030 (USD MILLION) 152 TABLE 96 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 153 TABLE 97 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 155 TABLE 98 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 156 TABLE 99 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 156 TABLE 100 HOSPITALS MARKET, BY REGION, 2022–2030 (USD MILLION) 157 TABLE 101 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS MARKET, BY REGION, 2022–2030 (USD MILLION) 158 TABLE 102 LONG-TERM CARE & ASSISTED LIVING FACILITIES MARKET, BY REGION, 2022–2030 (USD MILLION) 159 TABLE 103 HOME HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION) 160 TABLE 104 OTHER HEALTHCARE PROVIDERS MARKET, BY REGION, 2022–2030 (USD MILLION) 161 TABLE 105 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 162 TABLE 106 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION) 163 TABLE 107 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION) 164 TABLE 108 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION) 165 TABLE 109 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 166 TABLE 110 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION) 168 TABLE 111 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 170 TABLE 112 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 170 TABLE 113 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 170 TABLE 114 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 171 TABLE 115 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 171 TABLE 116 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 172 TABLE 117 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 172 TABLE 118 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 173 TABLE 119 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 173 TABLE 120 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 174 TABLE 121 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 175 TABLE 122 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 175 TABLE 123 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 175 TABLE 124 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 176 TABLE 125 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 176 TABLE 126 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 177 TABLE 127 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 177 TABLE 128 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 178 TABLE 129 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 178 TABLE 130 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 179 TABLE 131 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 179 TABLE 132 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 180 TABLE 133 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 180 TABLE 134 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 181 TABLE 135 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 181 TABLE 136 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 182 TABLE 137 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 182 TABLE 138 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 183 TABLE 139 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 184 TABLE 140 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 184 TABLE 141 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 185 TABLE 142 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 185 TABLE 143 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 185 TABLE 144 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 186 TABLE 145 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 186 TABLE 146 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 187 TABLE 147 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 187 TABLE 148 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 188 TABLE 149 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 189 TABLE 150 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 189 TABLE 151 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 189 TABLE 152 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 190 TABLE 153 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 190 TABLE 154 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 191 TABLE 155 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 191 TABLE 156 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 192 TABLE 157 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 192 TABLE 158 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 193 TABLE 159 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 194 TABLE 160 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 194 TABLE 161 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 194 TABLE 162 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 195 TABLE 163 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 195 TABLE 164 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 196 TABLE 165 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 196 TABLE 166 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 197 TABLE 167 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 198 TABLE 168 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 198 TABLE 169 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 198 TABLE 170 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 199 TABLE 171 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 199 TABLE 172 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 200 TABLE 173 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 200 TABLE 174 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 201 TABLE 175 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 201 TABLE 176 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 202 TABLE 177 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 203 TABLE 178 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 203 TABLE 179 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 203 TABLE 180 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 204 TABLE 181 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 204 TABLE 182 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 205 TABLE 183 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 205 TABLE 184 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 206 TABLE 185 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 207 TABLE 186 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 207 TABLE 187 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 207 TABLE 188 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 208 TABLE 189 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 208 TABLE 190 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 209 TABLE 191 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 209 TABLE 192 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 210 TABLE 193 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 210 TABLE 194 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 211 TABLE 195 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 211 TABLE 196 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 212 TABLE 197 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 212 TABLE 198 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 213 TABLE 199 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 213 TABLE 200 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 214 TABLE 201 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 214 TABLE 202 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 215 TABLE 203 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 217 TABLE 204 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 217 TABLE 205 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 217 TABLE 206 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 218 TABLE 207 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 218 TABLE 208 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 219 TABLE 209 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 219 TABLE 210 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 220 TABLE 211 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 220 TABLE 212 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 221 TABLE 213 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 222 TABLE 214 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 222 TABLE 215 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 222 TABLE 216 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 223 TABLE 217 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 223 TABLE 218 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 224 TABLE 219 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 224 TABLE 220 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 225 TABLE 221 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 225 TABLE 222 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 226 TABLE 223 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 226 TABLE 224 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 227 TABLE 225 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 227 TABLE 226 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 228 TABLE 227 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 228 TABLE 228 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 229 TABLE 229 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 229 TABLE 230 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 230 TABLE 231 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 231 TABLE 232 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 231 TABLE 233 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 231 TABLE 234 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 232 TABLE 235 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 232 TABLE 236 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 233 TABLE 237 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 233 TABLE 238 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 234 TABLE 239 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 234 TABLE 240 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 235 TABLE 241 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 235 TABLE 242 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 236 TABLE 243 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 236 TABLE 244 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 237 TABLE 245 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 237 TABLE 246 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 238 TABLE 247 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 238 TABLE 248 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 239 TABLE 249 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 240 TABLE 250 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 240 TABLE 251 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 241 TABLE 252 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 241 TABLE 253 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 241 TABLE 254 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 242 TABLE 255 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 242 TABLE 256 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 243 TABLE 257 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 243 TABLE 258 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 244 TABLE 259 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 245 TABLE 260 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 245 TABLE 261 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 246 TABLE 262 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 246 TABLE 263 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 247 TABLE 264 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 247 TABLE 265 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 248 TABLE 266 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 248 TABLE 267 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 249 TABLE 268 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 250 TABLE 269 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 250 TABLE 270 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 250 TABLE 271 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 251 TABLE 272 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 251 TABLE 273 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 252 TABLE 274 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 252 TABLE 275 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 253 TABLE 276 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER BY END USER, 2022–2030 (USD MILLION) 253 TABLE 277 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 254 TABLE 278 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 255 TABLE 279 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 255 TABLE 280 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 255 TABLE 281 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 256 TABLE 282 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 256 TABLE 283 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 257 TABLE 284 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 257 TABLE 285 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 258 TABLE 286 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION) 259 TABLE 287 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 259 TABLE 288 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 259 TABLE 289 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 260 TABLE 290 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 260 TABLE 291 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 261 TABLE 292 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 261 TABLE 293 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 262 TABLE 294 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 262 TABLE 295 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 263 TABLE 296 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 264 TABLE 297 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 264 TABLE 298 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 264 TABLE 299 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 265 TABLE 300 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 265 TABLE 301 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 266 TABLE 302 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 266 TABLE 303 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 267 TABLE 304 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 267 TABLE 305 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 268 TABLE 306 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 268 TABLE 307 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 269 TABLE 308 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 269 TABLE 309 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 270 TABLE 310 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 270 TABLE 311 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 271 TABLE 312 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 271 TABLE 313 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 272 TABLE 314 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021–MARCH 2025 273 TABLE 315 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION 278 TABLE 316 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT 282 TABLE 317 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT 283 TABLE 318 AI IN TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT 284 TABLE 319 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT 285 TABLE 320 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT 286 TABLE 321 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 289 TABLE 322 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION 289 TABLE 323 AI IN TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2025 292 TABLE 324 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2022–MARCH 2025 293 TABLE 325 MEDTRONIC: COMPANY OVERVIEW 294 TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 296 TABLE 327 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 297 TABLE 328 MEDTRONIC: DEALS, JANUARY 2022–MARCH 2025 298 TABLE 329 TELADOC HEALTH, INC.: COMPANY OVERVIEW 300 TABLE 330 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 302 TABLE 331 TELADOC HEALTH, INC.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 303 TABLE 332 TELADOC HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025 304 TABLE 333 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 306 TABLE 334 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 307 TABLE 335 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 309 TABLE 336 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MARCH 2025 309 TABLE 337 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 311 TABLE 338 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 313 TABLE 339 CISCO SYSTEMS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 314 TABLE 340 CISCO SYSTEMS, INC.: DEALS, JANUARY 2022–MARCH 2025 314 TABLE 341 GE HEALTHCARE: COMPANY OVERVIEW 316 TABLE 342 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 318 TABLE 343 GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 319 TABLE 344 GE HEALTHCARE: DEALS, JANUARY 2022–MARCH 2025 319 TABLE 345 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 321 TABLE 346 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 322 TABLE 347 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 323 TABLE 348 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–MARCH 2025 324 TABLE 349 ORACLE: COMPANY OVERVIEW 325 TABLE 350 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 327 TABLE 351 ORACLE: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 328 TABLE 352 ORACLE: DEALS, JANUARY 2022–MARCH 2025 329 TABLE 353 DOXIMITY, INC.: COMPANY OVERVIEW 331 TABLE 354 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 332 TABLE 355 DOXIMITY, INC.: PRODUCT UPGRADES, JANUARY 2022–MARCH 2025 333 TABLE 356 DOXIMITY, INC.: DEALS, JANUARY 2022–MARCH 2025 333 TABLE 357 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 334 TABLE 358 INCLUDED HEALTH, INC.: COMPANY OVERVIEW 335 TABLE 359 INCLUDED HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 335 TABLE 360 INCLUDED HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025 336 TABLE 361 INCLUDED HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 337 TABLE 362 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW 338 TABLE 363 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 339 TABLE 364 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2022–MARCH 2025 340 TABLE 365 AMERICAN WELL: COMPANY OVERVIEW 341 TABLE 366 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 342 TABLE 367 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 343 TABLE 368 AMERICAN WELL: DEALS, JANUARY 2022–MARCH 2025 344 TABLE 369 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 344 TABLE 370 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 345 TABLE 371 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 346 TABLE 372 SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 347 TABLE 373 AMC HEALTH: COMPANY OVERVIEW 348 TABLE 374 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 348 TABLE 375 AMC HEALTH: DEALS, JANUARY 2022–MARCH 2025 349 TABLE 376 TELESPECIALISTS: COMPANY OVERVIEW 350 TABLE 377 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 350 TABLE 378 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 351 TABLE 379 TELESPECIALISTS: DEALS, JANUARY 2022–MARCH 2025 351 TABLE 380 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 352 TABLE 381 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW 353 TABLE 382 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED 354 TABLE 383 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 355 TABLE 384 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2022–MARCH 2025 355 TABLE 385 CAREGILITY: COMPANY OVERVIEW 356 TABLE 386 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 356 TABLE 387 CAREGILITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 357 TABLE 388 CAREGILITY: DEALS, JANUARY 2022–MARCH 2025 357 TABLE 389 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 358 TABLE 390 CVS HEALTH: COMPANY OVERVIEW 359 TABLE 391 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 360 TABLE 392 CVS HEALTH: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 361 TABLE 393 ALIVECOR, INC.: COMPANY OVERVIEW 362 TABLE 394 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 362 TABLE 395 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025 363 TABLE 396 ALIVECOR, INC.: DEALS, JANUARY 2022–MARCH 2025 364 TABLE 397 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 365 TABLE 398 ELATION: COMPANY OVERVIEW 366 TABLE 399 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 366 TABLE 400 ELATION: DEALS, JANUARY 2022–MARCH 2025 367 TABLE 401 HEALTHTAP, INC.: COMPANY OVERVIEW 368 TABLE 402 HEALTHTAP, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 368 TABLE 403 HEALTHTAP, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 369 TABLE 404 HEALTHTAP, INC.: DEALS, JANUARY 2022–MARCH 2025 369 TABLE 405 CURAI HEALTH: COMPANY OVERVIEW 370 TABLE 406 ANDOR HEALTH: COMPANY OVERVIEW 371 TABLE 407 K HEALTH: COMPANY OVERVIEW 372 TABLE 408 TRANSACARENT: COMPANY OVERVIEW 373 TABLE 409 BIOINTELLISENSE, INC.: COMPANY OVERVIEW 374 FIGURE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 36 FIGURE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED 38 FIGURE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN 41 FIGURE 4 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES 43 FIGURE 5 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY PRIMARY SOURCES 44 FIGURE 6 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES 45 FIGURE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES 46 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 46 FIGURE 9 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 47 FIGURE 10 AI IN TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH 48 FIGURE 11 AI IN TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 50 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51 FIGURE 13 AI IN TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION 52 FIGURE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION) 55 FIGURE 15 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION) 56 FIGURE 16 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 57 FIGURE 17 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 58 FIGURE 18 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT 59 FIGURE 19 TECHNOLOGICAL ADVANCEMENTS AND NEED TO REDUCE HEALTHCARE EXPENSES TO PROPEL MARKET GROWTH 60 FIGURE 20 US AND SOFTWARE SEGMENT DOMINATED NORTH AMERICAN MARKET IN 2023 61 FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 62 FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER RATES DURING STUDY PERIOD 63 FIGURE 23 AI IN TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64 FIGURE 24 AMERICAN HOSPITAL ASSOCIATION (AHA) ANNUAL SURVEY ON EHR ADOPTION AMONG HOSPITALS AND OFFICE-BASED PHYSICIANS (2008–2021) 67 FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 73 FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 73 FIGURE 27 AI IN TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 76 FIGURE 28 AI IN TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS 77 FIGURE 29 AI IN TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS 79 FIGURE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 100 FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 102 FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 103 FIGURE 33 GLOBAL PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, 2015–2025 104 FIGURE 34 JURISDICTION & TOP APPLICANT ANALYSIS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 105 FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (JANUARY 2015–MARCH 2025) 106 FIGURE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024 111 FIGURE 37 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 169 FIGURE 38 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 216 FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, 2020–2024 (USD MILLION) 276 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET (2023) 277 FIGURE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 280 FIGURE 42 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 281 FIGURE 43 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 288 FIGURE 44 EV/EBITDA OF KEY AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024 290 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024 290 FIGURE 46 AI IN TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 291 FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT 295 FIGURE 48 TELADOC HEALTH, INC.: COMPANY SNAPSHOT 301 FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 307 FIGURE 50 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT 312 FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT 317 FIGURE 52 ORACLE: COMPANY SNAPSHOT 326 FIGURE 53 DOXIMITY, INC.: COMPANY SNAPSHOT 332 FIGURE 54 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT 339 FIGURE 55 AMERICAN WELL: COMPANY SNAPSHOT 342 FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 346 FIGURE 57 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT 354 FIGURE 58 CVS HEALTH: COMPANY SNAPSHOT 360